JP2011521930A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521930A5
JP2011521930A5 JP2011511053A JP2011511053A JP2011521930A5 JP 2011521930 A5 JP2011521930 A5 JP 2011521930A5 JP 2011511053 A JP2011511053 A JP 2011511053A JP 2011511053 A JP2011511053 A JP 2011511053A JP 2011521930 A5 JP2011521930 A5 JP 2011521930A5
Authority
JP
Japan
Prior art keywords
group
formula
natural
modified
protected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011511053A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521930A (ja
JP5689054B2 (ja
Filing date
Publication date
Priority claimed from FR0802928A external-priority patent/FR2931824B1/fr
Application filed filed Critical
Publication of JP2011521930A publication Critical patent/JP2011521930A/ja
Publication of JP2011521930A5 publication Critical patent/JP2011521930A5/ja
Application granted granted Critical
Publication of JP5689054B2 publication Critical patent/JP5689054B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011511053A 2008-05-29 2009-05-28 Rna化学合成方法 Expired - Fee Related JP5689054B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0802928 2008-05-29
FR0802928A FR2931824B1 (fr) 2008-05-29 2008-05-29 Procede de synthese d'arn par voie chimique.
PCT/FR2009/000624 WO2009144418A1 (fr) 2008-05-29 2009-05-28 Procede de synthese d'arn par voie chimique

Publications (3)

Publication Number Publication Date
JP2011521930A JP2011521930A (ja) 2011-07-28
JP2011521930A5 true JP2011521930A5 (cg-RX-API-DMAC7.html) 2014-07-24
JP5689054B2 JP5689054B2 (ja) 2015-03-25

Family

ID=39712442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511053A Expired - Fee Related JP5689054B2 (ja) 2008-05-29 2009-05-28 Rna化学合成方法

Country Status (7)

Country Link
US (1) US8536318B2 (cg-RX-API-DMAC7.html)
EP (1) EP2303905B1 (cg-RX-API-DMAC7.html)
JP (1) JP5689054B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910689A2 (cg-RX-API-DMAC7.html)
CA (1) CA2726260C (cg-RX-API-DMAC7.html)
FR (1) FR2931824B1 (cg-RX-API-DMAC7.html)
WO (1) WO2009144418A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011028218A1 (en) 2009-09-02 2011-03-10 Alnylam Pharmaceuticals, Inc. Process for triphosphate oligonucleotide synthesis
EP2600901B1 (en) 2010-08-06 2019-03-27 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
MX2013003681A (es) 2010-10-01 2013-11-20 Moderna Therapeutics Inc Ácidos nucleicos manipulados y métodos de uso de los mismos.
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9428535B2 (en) 2011-10-03 2016-08-30 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
SMT202200355T1 (it) 2011-12-16 2022-11-18 Modernatx Inc Composizioni di mrna modificato
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP2834260A4 (en) 2012-04-02 2016-08-10 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PREPARATION OF MEMBRANE PROTEINS
WO2014017615A1 (ja) 2012-07-25 2014-01-30 国立大学法人高知大学 Rna合成用モノマー、その製造方法、およびrnaの製造方法
EP2922554B1 (en) 2012-11-26 2022-02-23 ModernaTX, Inc. Terminally modified rna
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
PL221806B1 (pl) 2013-03-21 2016-05-31 Inst Chemii Bioorg Polskiej Akademii Nauk Sposób wprowadzania acetalowych i acetaloestrowych grup ochronnych oraz związki do realizacji tego sposobu
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
JP2016538829A (ja) 2013-10-03 2016-12-15 モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. 低密度リポタンパク質受容体をコードするポリヌクレオチド
ES2806575T3 (es) 2013-11-01 2021-02-18 Curevac Ag ARN modificado con propiedades inmunoestimuladoras disminuidas
EP3542802A1 (en) 2013-11-01 2019-09-25 CureVac AG Modified rna with decreased immunostimulatory properties
US20170204152A1 (en) 2014-07-16 2017-07-20 Moderna Therapeutics, Inc. Chimeric polynucleotides
WO2023097308A1 (en) * 2021-11-29 2023-06-01 Hongene Biotech Corporation Synthesis of 2' acetyl-ester protected nucleosides
CN114685572B (zh) * 2022-06-02 2022-08-30 上海百力格生物技术有限公司 用于mgb核酸探针合成的氧化剂组合物及探针的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
EP1386925A1 (en) * 2002-07-31 2004-02-04 Girindus AG Method for preparing oligonucleotides
CN100484949C (zh) * 2005-07-18 2009-05-06 张必良 用于rna寡核苷酸合成中的核苷亚磷酰胺及其合成方法

Similar Documents

Publication Publication Date Title
JP2011521930A5 (cg-RX-API-DMAC7.html)
JP5689054B2 (ja) Rna化学合成方法
JP7492829B2 (ja) 多重カップリングおよび酸化の方法
CN112533892B (zh) 烷氧基苯基衍生物、核苷保护体和核苷酸保护体、寡核苷酸制造方法以及取代基除去方法
FI3794012T3 (fi) Koostumuksia ja menetelmiä pintaan sitoutuneiden oligonukleotidien kemiallista pilkkomista ja suojauksen poistoa varten
JP5925383B2 (ja) 光クロスリンク能を有する光応答性ヌクレオチドアナログ
CN106255697A (zh) 磷保护基团及其制备方法和用途
CN110719912B (zh) 在可见光区能进行光交联的光响应性核苷酸类似物
EP3601309A1 (en) Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides
JP2011184318A (ja) リボヌクレシドh−ボラノホスホネート
CN1997658A (zh) 合成被保护的3′-氨基核苷单体
JPWO2017218454A5 (cg-RX-API-DMAC7.html)
JP7004480B2 (ja) ソホスブビルの調製のための改善された製造方法
AU2018298658B2 (en) Improved process for preparing imetelstat
US7166718B2 (en) Calix[4]arene-nucleoside and calix[4]oligonucleotide hybrids
JPH069682A (ja) レトロウイルス感染用治療薬としてのポリヌクレオチドホスホロジチオエート
CA2685515A1 (en) Synthesis of oligonucleotides
JP2020132604A (ja) 核酸合成用固相担体及びそれを用いた核酸の製造方法
KR20070101870A (ko) 올리고뉴클레오티드의 정제
Nukaga et al. Chemical Synthesis of Boranophosphate Deoxy-ribonucleotides
JP2018184351A (ja) ヌクレオシド又はそのヌクレオチドの誘導体、それを構成単位として含むrna誘導体、核酸医薬、及びrna誘導体若しくはrnaの製造方法
CN118632854A (zh) 亚磷酰胺单体
CN119173522A (zh) 方法和化合物
WO2024143276A1 (ja) オリゴヌクレオチドの製造方法
JP2025536748A (ja) 標的化リガンドコンジュゲート化ヌクレオチドホスホラミダイトを合成する方法